Skip to content
Merck on July 27 announced positive Phase 3 results for a new pneumococcal conjugate vaccine, which targets several varieties of bacteria that cause pneumococcal pneumonia. […]
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial Read More »
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with
The World Health Organization (WHO) reports that routine vaccination rates among children have increased, although there’s room for improvement. According to UNICEF and WHO
Routine immunization among kids is improving Read More »
Creative individuals are spearheading imaginative approaches as biotech battles cancer, the leading cause of death worldwide. Profiles of leaders from a cancer institute and
Innovators describe biotech advances against cancer in I am BIO videos Read More »
A new antibiotic that could potentially be effective against many superbugs, tuberculosis, and even “untreatable” illnesses has been discovered, reports Nature, using none other
From AI to antibiotics: Can machine learning help us fight superbugs? Read More »
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
Federal support empowers a public-private partnership that helps ensure U.S. leadership in drug development—and the relationship should not be changed by calls for arbitrary
BIO expert lauds beautiful relationship between NIH and biotech Read More »
In the aftermath of the COVID-19 pandemic, it’s important to explore the impact of the pandemic on other infectious diseases, such as hepatitis. There
Why we need to address the impact of COVID-19 on hepatitis Read More »
COVID-19 has affected the world for nearly four years, persisting in its consequences through post-viral syndrome. Scientists are gaining deeper insights into the causes
Unraveling causes of long COVID to find potential treatments Read More »
A boy with a rare genetic condition has regained his sight thanks to creative “off-label” use of a gene therapy—an innovative approach that current
Off-label use of a gene therapy returns sight for boy with rare disease Read More »
